Growth Plate Disturbances in Renal Failure

Clinical Reviews in Bone and Mineral Metabolism

Volumn 2, Issue 1, 2004, Pages 53-61

  Kuizon, Beatriz D ^a   Salusky, Isidro B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adynamic bone; Growth plates; Renal failure; Secondary hyperparathyroidism

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS; SOMATOMEDIN; SOMATOMEDIN C;

BONE DEFORMATION; BONE GROWTH; CALCIUM INTAKE; CARTILAGE CELL; CHRONIC KIDNEY FAILURE; DISEASE SEVERITY; GROWTH PLATE; GROWTH RETARDATION; HYPERTROPHY; KIDNEY FAILURE; LONG BONE; NONHUMAN; OSTEOCLAST; RAT; REGULATORY MECHANISM; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 1542348520     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:2:1:53     Document Type: Review

References (51)

1. Hunziker EB. 1994 Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Tech 28(6):505-519.
2. Kronenberg HM. 2003 Developmental regulation of the growth plate. Nature 423(6937):332-336.
3. Ballock RT, O'Keefe RJ. 2003 The biology of the growth plate. J Bone Joint Surg Am 85-A(4):715-726.
4. Alvarez J, Sohn P, Zeng X, Doetschman T, Robbins DJ, Serra R. 2002 TGFbeta2 mediates the effects of hedgehog on hypertrophic differentiation and PTHrP expression. Development 129(8):1913-1924.
5. Lanske B, Karaplis AC, Lee K, Luz, A, Vortkamp, A, Pirro, A, et al. 1996 PTH/PTHrP receptor in early development and Indian Hedgehog-regulated bone growth. Science 273:663-666.
6. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, et al. 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes & Development 8:277-289.
7. Karaplis AC, He B, Nguyen MTA, Young ID, Semeraro D, Ozawa H, Amizuka N. 1998 Inactivating mutation in the human parathyroid hormone receptor type I gene in Blomstrand Chondrodysplasia. Endocrinology 139:5255-5258.
8. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE. 1996 Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93:10240-10245.
9. Schipani E, Kruse K, Jüppner HA. 1995 Constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100.
10. St Jacques B, Hammerschmidt M, McMahon AP. 1999 Indian Hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone for mation. Genes Dev 13(16):2072-2086.
11. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96(13):7324-7329.
12. Cobo A, Carbajo E, Santos F, Garcia E, Lopez JM. 1996 Morphometry of uremic rat growth plate. Miner Electrolyte Metab 22(1-3):192-195.
13. Mehls O, Ritz E, Hunziker EB, Eggli P, Heinrich U, Zapf J. 1988 Improvement of growth and food utilization by recombinant human growth hormone in uremia. Kidney Int 33:45-52.
14. Hanna JD, Santos F, Foreman JW, Chan JCM, Han VKM. 1995 Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. Kidney Int 47:1374-1382.
15. Cobo A, Lopez JM, Carbajo E, Santos F, Alvarez J, Fernandez M, Weruaga A. 1999 Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J Am Soc Nephrol 10(5):971-979.
16. Alvarez J, Balbin M, Fernandez M, Lopez JM. 2001 Collagen metabolism is markedly altered in the hypertrophic cartilage of growth plates from rats with growth impairment secondary to chronic renal failure. J Bone Min Res 16(3):511-524.
17. Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Jüppner H, Goodman WG. 1998 Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887.
18. Sanchez CP, Kuizon BD, Abdella PA, Jüppner H, Salusky IB, Goodman WG. 2000 Impaired growth, delayed ossification, and reduced osteoclastic activty in the growth plate of calcium-supplemented rats with renal failure. Endocrinology 141:1536-1544.
19. Ureña P, Kubrusly M, Mannstadt M, Hruby M, Tan MMTT, Silve C, Lacour B, et al. 1994 The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605-611.
20. Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, Gokal R, Hoyland JA. 2000 Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58(4):1440-1449.
21. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. 1998 MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
22. Gerber H-P, Vu TH, Ryan AM, Kowalki J, Werb Z, Ferrarra N. 1999 VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
23. Sanchez CP, He YZ. 2003 Effects of thyroparathyroidectomy, exogenous calcium, and short-term calcitriol therapy on the growth plate in renal failure. J Am Soc Nephrol 14(1):148-158.
24. Samaan NA, Freeman RM. 1970 Growth hormone levels in severe renal failure. Metabolism 19:102-113.
25. Tonshoff B, Cronin MJ, Reichert M, Haffner D, Wingen AM, Blum WF, Mehls O, The European Study Group for Nutritional Treatment of Chronic Renal failure in Childhood, and Members of the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. 1997 Reduced concentration of serum growth hormone (GH)binding protein in children with chronic renal failure: correlation with GH insensitivity. J Clin Endocrinol Metab 82:1007-1013.
26. Chan W, Valerie KC, Chan JCM. 1993 Expression of insulin-like growth factor-1 in uremic rats. Kidney Int 43:790-796.
27. Tonshoff B, Eden S, Weiser E, Carlsson B, Robinson LC, Blum WF, Mehls O. 1994 Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 45:1085-1092.
28. Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R. 2001. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J.Clin.Invest 108(3):467-475.
29. Powell D, Liu F, Baker BK, Hintz RL, Lee PDK, Durham SK, et al. 1997 Modulation of growth factors by growth hormone in children with chronic renal failure. Kidney Int 51:1970-1979.
30. Tonshoff B, Blum WF, Mehls O. 1997 Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int Suppl 58:S106-S113.
31. Ulinski T, Mohan S, Kiepe D, Blum WF, Wingen AM, Mehls O, Tonshoff B. 2000 Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth glomular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 14(7):589-597.
32. Kiepe D, Andress DL, Mohan S, Standker L, Ulinski T, Himmele R, et al. 2001. Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. J Am Soc Nephrol 12(11):2400-2410.
33. Kiepe D, Ulinski T, Powell DR, Durham SK, Mehls O, Tonshoff B. 2002 Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int 62(5):1591-1600.
34. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S. 2001 Evidence that IGF-binding protein-5 functions as a growth factor. J.Clin.Invest 107(1):73-81.
35. Richman C, Baylink DJ, Lang K, Dony C, Mohan S. 1999 Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140(10):4699-4705.
36. Edmondson SR, Mehls O, Oh J, Mehls O. 2000 Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Kidney Int 58:62-70.
37. Green J, Maor, G. 2000 Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers. Kidney Int 57:2258-2267.
38. Chesney RW, Moorthy AV, Eisman JA, Tax DK, Mazess RB, DeLuca HF. 1978 Increased growth after long-term oral 1,25-vitamin D3 in childhood renal osteodystrophy. NEJM 298:238-242.
39. Chan JC, Kodroff MB, Landwehr DM. 1981 Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure. Pediatrics 68:559-571.
40. Hodson EM, Evans RA, Dunstan CR, et al. 1985 Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol. Clin Nephrol 24:192-200.
41. Chan JCM, McEnery PT, Chinchilli VM, Abitbol CL, Boineau FG, Friedman AL, et al. 1994 A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. J Ped 124:520-528.
42. Salusky IB, Fine RN, Kangarloo H, Gold R, Paunier L, Goodman WG, et al. 1987 "High-dose" calcitriol for control of renal osteodystrophy in children on CAPD. Kidney Int 32:89-95.
43. Kuizon BD, Goodman WG, Jüppner H, Boechat I, Nelson P, Gales B, et al. 1998. Diminished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure. Kidney Int 53:205-211.
44. Saggese G, Federico G, Cinquanta L. 1993. In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatrica (Suppl.) 391:54-59.
45. Scharla SH, Strong DD, Mohan S, Baylink DJ, Linkhart TA. 1991 1,25-dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor-I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146.
46. Silbermann M, Mirsky N, Levitan S, Weisman Y. 1983 The effect of 1,25-dihydroxyvitamin D3 on cartilage growth in neonatal mice. Met Bone Dis Rel Res 4:337-345.
47. Weinreb M Jr, Gazit E, Weinreb MM. 1986 Mandibular growth and histologic changes in condylar cartilage of rats intoxicated with vitamin D3 or 1,25(OH) 2D3 and pair-fed (undernourished) rats. J Dent Res 65(12):1449-1452.
48. Kainer G, Nakano M, Massie FS, Jr, Foreman JW, Chan JCM. 1991 Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats. Ped Res 30:528-533.
49. Colston KW, Perks CM, Xie SP, Holly JM. 1998 Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol 20(1):157-162.
50. Nickerson T. Huynh H. 1999 Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins. J Endocrinol 160(2):223-229.
51. Kuizon BD. and Salusky IB. Cell Biology of Renal Osteodystrophy. Pediatric Nephrology 2002;17(10):777-89.